Carl Zeiss Meditec AG (OTCMKTS:CZMWY) Given Average Rating of “Hold” by Analysts

Shares of Carl Zeiss Meditec AG (OTCMKTS:CZMWY) have earned an average recommendation of “Hold” from the six analysts that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and one has assigned a buy recommendation to the company.

A number of research analysts have recently issued reports on the stock. UBS Group downgraded shares of Carl Zeiss Meditec from a “neutral” rating to a “sell” rating in a research report on Tuesday. Zacks Research raised shares of Carl Zeiss Meditec from a “strong sell” rating to a “hold” rating in a research note on Monday, July 13th.

Carl Zeiss Meditec Stock Performance

OTCMKTS CZMWY opened at $34.63 on Tuesday. Carl Zeiss Meditec has a twelve month low of $26.65 and a twelve month high of $55.94. The stock has a fifty day simple moving average of $31.96 and a 200 day simple moving average of $31.12.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG is a global medical technology company headquartered in Jena, Germany. Founded in 2002 as a spin-off from the Carl Zeiss Group, the business leverages the parent company’s expertise in optics and precision engineering. Over the years, Carl Zeiss Meditec has grown through organic development and strategic acquisitions, becoming a recognized provider of innovative surgical and diagnostic solutions for eye care and microsurgery.

The company’s core offerings span two primary divisions: Ophthalmic Devices and Microsurgery.